Cargando…
Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292177/ https://www.ncbi.nlm.nih.gov/pubmed/32743460 http://dx.doi.org/10.1002/iju5.12132 |
| _version_ | 1783546055521992704 |
|---|---|
| author | Tomisaki, Ikko |
| author_facet | Tomisaki, Ikko |
| author_sort | Tomisaki, Ikko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7292177 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72921772020-07-30 Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer Tomisaki, Ikko IJU Case Rep Editorial Comment John Wiley and Sons Inc. 2019-12-02 /pmc/articles/PMC7292177/ /pubmed/32743460 http://dx.doi.org/10.1002/iju5.12132 Text en © 2019 The Author. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Editorial Comment Tomisaki, Ikko Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer |
| title | Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer |
| title_full | Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer |
| title_fullStr | Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer |
| title_full_unstemmed | Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer |
| title_short | Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer |
| title_sort | editorial comment to pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292177/ https://www.ncbi.nlm.nih.gov/pubmed/32743460 http://dx.doi.org/10.1002/iju5.12132 |
| work_keys_str_mv | AT tomisakiikko editorialcommenttopembrolizumabinducedmyastheniagraviswithmyositisandpresumablemyocarditisinapatientwithbladdercancer |